Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Accolade (ACCD)
NASDAQ:ACCD
Accolade (ACCD) Stock Price & Analysis
335 Followers
ACCD Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$6.33 - $17.01
Previous Close$8.7
Volume772.75K
Average Volume (3M)604.78K
Market Cap
$673.45M
Enterprise Value$685.13M
Total Cash (Recent Filing)$230.02M
Total Debt (Recent Filing)$241.70M
Price to Earnings (P/E)-5.2
Beta2.49
Next Earnings
Apr 25, 2024EPS Estimate
-$0.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.66
Shares Outstanding77,407,607
10 Day Avg. Volume582,356
30 Day Avg. Volume604,781
Standard Deviation0.22
R-Squared0.22
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)-36.08
Price to Sales (P/S)6.80
Price to Cash Flow (P/CF)31.20
P/FCF Ratio108.90
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.76
Enterprise Value/Gross Profit4.17
Enterprise Value/Ebitda-9.56
Forecast
1Y Price Target
$15.00Price Target Upside63.58% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5
Accolade News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceAccolade is on the tipping point of hitting revenue growth and profitability goals through natural leverage and targeted cost cuts.
Market Demand And Revenue VisibilityEnd Market Demand Appears Strong with management noting plenty of opportunity and ability to offer cost trends bending.
Product Expansion And Customer Base GrowthAccolade's acquisitions have expanded its customer base and service offerings, enhancing cross-selling opportunities.
Bears Say
Customer RetentionRecent reports show a decline in gross retention, raising concerns about the company's ability to maintain its current growth trajectory.
Debt ObligationsThe company's convertible loan due in April places limitations on its ability to engage in mergers and acquisitions, despite having the means to settle the debt.
Operating EnvironmentThe operating environment may pose challenges to future financial estimations, potentially impacting the stock's performance.
---
Ownership Overview
29.58% Insiders
20.60% Mutual Funds
26.84% Other Institutional Investors
22.98% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ACCD FAQ
What was Accolade’s price range in the past 12 months?
Accolade lowest stock price was $6.33 and its highest was $17.00 in the past 12 months.
What is Accolade’s market cap?
Currently, no data Available
When is Accolade’s upcoming earnings report date?
Accolade’s upcoming earnings report date is Apr 25, 2024 which is in 6 days.
How were Accolade’s earnings last quarter?
Accolade released its earnings results on Jan 08, 2024. The company reported -$0.28 earnings per share for the quarter, beating the consensus estimate of -$0.447 by $0.167.
Is Accolade overvalued?
According to Wall Street analysts Accolade’s price is currently Undervalued.
Does Accolade pay dividends?
Accolade does not currently pay dividends.
What is Accolade’s EPS estimate?
Accolade’s EPS estimate is -$0.11.
How many shares outstanding does Accolade have?
Accolade has 77,407,610 shares outstanding.
What happened to Accolade’s price movement after its last earnings report?
Accolade reported an EPS of -$0.28 in its last earnings report, beating expectations of -$0.447. Following the earnings report the stock price went up 29.002%.
Which hedge fund is a major shareholder of Accolade?
Among the largest hedge funds holding Accolade’s share is ARK Investment Management LLC. It holds Accolade’s shares valued at 82M.
---
Accolade Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$15.00 (63.58% Upside)
$15.00 (63.58% Upside)
Blogger Sentiment
Bullish
ACCD Sentiment 75%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 182.4K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▲ 0.3%
Last 30 Days ▼ 4.3%
Last 30 Days ▼ 4.3%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-40.41%
12-Months-Change
Fundamentals
Return on Equity
-26.66%
Trailing 12-Months
Asset Growth
-14.04%
Trailing 12-Months
Company Description
Accolade
Accolade Inc offers technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits. it generates revenue through providing personalized health guidance solutions to members.
---
ACCD Company Deck
---
ACCD Earnings Call
Q3 2024
0:00 / 0:00
---
ACCD Stock 12 Months Forecast
Average Price Target
$15.00
▲(63.58% Upside)
Technical Analysis
Aclaris Therapeutics
―
Acadia Healthcare
―
Achieve Life Sciences
―
ACADIA Pharmaceuticals
―
Best Analysts Covering ACCD
1 Year
1 Year Success Rate
6/16 ratings generated profit
1 Year Average Return
-11.53%
reiterated a buy rating 3 months ago
Copying Ryan MacDonald's trades and holding each position for 1 Year would result in 37.50% of your transactions generating a profit, with an average return of -11.53% per trade.
---